Sphygmomanometer Market Growth Patterns And Forecast Outlook Through 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Sphygmomanometer Market From 2026 To 2030?

The sphygmomanometer market has demonstrated significant expansion recently. It is projected to increase from $3.2 billion in 2025 to $3.53 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.3%. The growth observed in prior periods can be attributed to the rising prevalence of hypertension, widespread use of mercury-based devices historically, increased screening in clinical settings, growth of primary healthcare facilities, and the adoption of manual and aneroid devices.

The sphygmomanometer market is projected to experience swift expansion over the coming years. This market is anticipated to reach $5.31 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. Factors contributing to this growth during the projected timeframe include a greater need for remote patient observation, the wider embrace of connected healthcare tools, the broadening of telemedicine offerings, an increased emphasis on proactive cardiovascular health, and the ongoing substitution of mercury-based devices. Key developments anticipated within this forecast period encompass a surge in the uptake of digital blood pressure monitors, an escalating preference for at-home monitoring options, the expanding incorporation of data connectivity functionalities, the proliferation of portable and wearable setups, and a heightened emphasis on precise measurements and user-friendliness.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/sphygmomanometer-global-market-report

What Key Factors Are Shaping The Sphygmomanometer Market Landscape?

The increasing prevalence of chronic non-communicable diseases (NCDs) is projected to fuel the expansion of the sphygmomanometer market. These persistent health conditions, especially hypertension and cardiovascular disease, are characterized by slow progression and the need for continuous oversight and care. Hypertension, a significant global health concern and a primary risk factor for cardiovascular issues, underscores the importance of consistent blood-pressure monitoring for early detection and effective management. The rising incidence of these conditions is influenced by demographic and lifestyle factors such as an aging global population, poor dietary habits, insufficient physical activity, and increasing obesity rates, all contributing to a worldwide increase in blood-pressure irregularities. Sphygmomanometers play a crucial role in patient care by enabling prompt diagnosis, continuous monitoring, and enhanced cardiovascular risk management across both clinical and home-care environments. For instance, according to the World Health Organization (WHO), a Switzerland-based agency of the United Nations, in September 2025, an estimated 1.4 billion adults aged 30–79 were affected by hypertension in 2024, representing 33 percent of this age group, with two-thirds residing in low- and middle-income countries. Additionally, roughly 600 million individuals (44 percent) remained undiagnosed, while approximately 630 million (44 percent) had received diagnosis and treatment, highlighting the substantial global burden of the condition. Consequently, the growing burden of chronic NCDs is a significant catalyst for the growth of the sphygmomanometer market. The expansion in the number of ambulatory surgery centers is expected to drive the growth of the sphygmomanometer market moving forward. An Ambulatory Surgical Center (ASC) is a specialized medical facility where surgical procedures are performed without requiring an overnight hospital stay. These centers significantly rely on sphygmomanometers, also known as blood pressure cuffs, for monitoring patients’ vital signs before, during, and after surgical operations. For example, in July 2025, CliftonLarsonAllen LLP, a US-based professional services firm, reported that ambulatory surgery centers are increasing in size and usage, with over 10,000 facilities operating across the United States. The industry’s revenues are projected to grow from approximately USD 45 billion in 2024 to about USD 57 billion by 2030. Therefore, the increasing presence of ambulatory surgery centers is a key factor propelling the expansion of the sphygmomanometer market.

How Are Segments Identified Within The Sphygmomanometer Market Segment Framework?

The sphygmomanometer market covered in this report is segmented –

1) By Product: Electronic Sphygmomanometer, Aneroid Sphygmomanometer, Mercury Sphygmomanometer

2) By Configuration: Portable, Desk Mounted, Floor Standing, Wall Mounted

3) By Operation: Electric, Manual, Automatic, Semi-automatic

4) By End User: Hospitals, Ambulatory Surgical Centers And Clinics, Home Healthcare, Other End Users

Subsegments:

1) By Electronic Sphygmomanometer: Upper Arm Electronic Sphygmomanometer, Wrist Electronic Sphygmomanometer, Finger Electronic Sphygmomanometer

2) By Aneroid Sphygmomanometer: Manual Aneroid Sphygmomanometer, Digital Aneroid Sphygmomanometer

3) By Mercury Sphygmomanometer: Standard Mercury Sphygmomanometer, Portable Mercury Sphygmomanometer

What Market Trends Are Affecting The Sphygmomanometer Market?

Leading companies within the sphygmomanometer market are prioritizing the development of advanced automatic blood pressure monitoring solutions that integrate AI-driven diagnostic functionalities. These efforts aim to enhance measurement accuracy, aid in the early detection of cardiovascular abnormalities, and increase the ease of home-based health monitoring. AI-enabled automatic blood pressure monitors leverage machine-learning algorithms to scrutinize pulse-wave signals during cuff inflation, allowing these devices to identify irregular heart rhythms such as atrial fibrillation (AFib) while concurrently providing reliable systolic and diastolic readings. For instance, in November 2024, OMRON Healthcare, a Japan-based health equipment, software, and service provider, obtained FDA De Novo authorization for its subsequent generation home blood pressure monitor. This device features IntelliSense AFib, an AI-powered AFib detection algorithm that assesses more than 300 pulse-wave indices and exhibits high diagnostic precision, with clinical performance showing 95% sensitivity and 98% specificity. This innovation exemplifies the evolution of automatic oscillometric devices from basic blood-pressure measurement instruments into comprehensive cardiovascular screening technologies that support early detection, continuous monitoring, and enhanced clinical decision-making.

Who Are The Companies Competing Within The Sphygmomanometer Market?

Major companies operating in the sphygmomanometer market are A&D Company Ltd., American Diagnostic Corporation, Omron Healthcare Inc., Microlife Corporation, Beurer GmbH, CIGA Healthcare Ltd., Rossmax International Ltd., Rudolf Riester GmbH, Welch Allyn Inc., Koninklijke Philips N.V., Paul Hartmann AG, Spengler, Holtex Ltd., Timesco Healthcare Ltd., Bremed Ltd., iHealth Labs Inc., Contec Medical Systems Co. Ltd., SunTech Medical Inc., General Electric Company, Amico Group of Companies, HEINE Optotechnik GmbH and Co. KG, Hill-Rom Services Inc., Halma plc

Get The Full Sphygmomanometer Market Report:

https://www.thebusinessresearchcompany.com/report/sphygmomanometer-global-market-report

Which Region Leads The Sphygmomanometer Market In Overall Market Size?

North America was the largest region in the sphygmomanometer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global sphygmomanometer market during the forecast period. The regions covered in the sphygmomanometer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Sphygmomanometer Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/sphygmomanometer-global-market-report

Browse Through More Reports Similar to the Global Sphygmomanometer Market 2026, By The Business Research Company

Digital Or Electrical Sphygmomanometer Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-or-electrical-sphygmomanometer-global-market-report

Spirometer Market Report 2026

https://www.thebusinessresearchcompany.com/report/spirometer-global-market-report

Bone Densitometer Market 2026

https://www.thebusinessresearchcompany.com/report/bone-densitometer-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795